Showing results (91-100 of 108) with videos related to

Sort By:
Pageof 11
Neuroscience Letters|February 2, 2010
Selection of optimal passage of bone marrow-derived mesenchymal stem cells for stem cell therapy in patients with amyotrophic lateral sclerosisMi Ran Choi, Hyun Young Kim, Ji-Yoon Park, et al.
Toxicology in Vitro : an International Journal Published in Association with BIBRA|July 13, 2010
Effects of acute ethanol treatment on NCCIT cells and NCCIT cell-derived embryoid bodies (EBs)Kyoung Hwa Jung, Nando Dulal Das, Ji Hyun Park, et al.
Marine Drugs|September 22, 2022
Echinochrome A Inhibits Melanogenesis in B16F10 Cells by Downregulating CREB SignalingMi Ran Choi, Heejin Lee, Hyoung Kyu Kim, et al.
Brain Research|July 19, 2008
Implantation of human umbilical cord-derived mesenchymal stem cells as a neuroprotective therapy for ischemic stroke in ratsSeong-Ho Koh, Kyung Suk Kim, Mi Ran Choi, et al.
Phytotherapy Research : PTR|April 22, 2011
Terminalia chebula extract acts as a potential NF-κB inhibitor in human lymphoblastic T cellsNando Dulal Das, Kyoung Hwa Jung, Ji Hyun Park, et al.
Foods (Basel, Switzerland)|September 9, 2022
Food and Gut Microbiota-Derived Metabolites in Nonalcoholic Fatty Liver DiseaseMin Kyo Jeong, Byeong Hyun Min, Ye Rin Choi, et al.
Frontiers in Microbiology|June 19, 2023
Multi-strain probiotics alleviate loperamide-induced constipation by adjusting the microbiome, serotonin, and short-chain fatty acids in ratsJin-Ju Jeong, Raja Ganesan, Yoo-Jeong Jin, et al.
Cells|September 23, 2022
Elucidation of Prebiotics, Probiotics, Postbiotics, and Target from Gut Microbiota to Alleviate Obesity via Network Pharmacology StudyKi-Kwang Oh, Haripriya Gupta, Byeong-Hyun Min, et al.
Scientific Reports|January 13, 2023
The identification of metabolites from gut microbiota in NAFLD via network pharmacologyKi-Kwang Oh, Haripriya Gupta, Byeong Hyun Min, et al.
Artificial Cells, Nanomedicine, and Biotechnology|May 2, 2023
The seamless integration of dietary plant-derived natural flavonoids and gut microbiota may ameliorate non-alcoholic fatty liver disease: a network pharmacology analysisKi-Kwang Oh, Haripriya Gupta, Raja Ganesan, et al.
Pageof 11